Archives
-
PPARα Activation Limits Pyroptosis in Cholestatic Injury
2026-08-19
The 2026 Liver Research study identifies two pyroptotic pathways suppressed by PPARα activation in lithocholic acid-induced cholestatic liver injury: NLRP3 inflammasome signaling and the APAF-1/CASPASE-3/GSDME axis. Its integrated biochemical, histological, ultrastructural, and molecular design provides a framework for evaluating PPARα as a mechanistic target in cholestatic liver disease.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-08-19
The Hoechst 33342/PI Double Staining Kit (SKU K2237) provides a two-color fluorescence workflow for comparing nuclear chromatin changes with loss of cell membrane integrity in cultured cells. It is intended for basic scientific research and microscopy-based cell death assessment, not for diagnostic, clinical, or medical use.
-
Chemoproteomic SLC15A4 Inhibitors and Inflammation
2026-08-18
Chiu and colleagues used integrated chemical proteomics to develop functional small-molecule inhibitors of the endolysosomal transporter SLC15A4. The compounds suppressed TLR7–9 and NOD signaling across immune-cell systems and provided in vivo and patient-cohort evidence that SLC15A4 is a tractable target for autoimmune and autoinflammatory disease research.
-
Cyanine 3 Tyramide in Brain Circuit Research
2026-08-18
Cyanine 3 Tyramide offers a strategically useful route to high-sensitivity spatial readouts in neuroscience. By connecting Tyramide Signal Amplification with emerging evidence on early life adversity, oxytocin signaling, and superior colliculus circuitry, this article outlines how translational researchers can strengthen assay design without overstating clinical readiness.
-
Annexin V-PE Reagent for Early Apoptosis
2026-08-17
The Annexin V-PE Reagent is an Annexin V fluorescent conjugate for rapid phosphatidylserine externalization detection during early apoptosis. Its one-step, 15–30 minute staining workflow supports flow cytometry and fluorescence microscopy, provided that calcium-containing binding conditions and appropriate controls are used.
-
Biotin-tyramide (A8011): TSA Workflow Guide
2026-08-17
Biotin-tyramide is a biotinylation reagent for HRP-driven tyramide signal amplification in fixed-cell and tissue workflows, including immunohistochemistry (IHC) and in situ hybridization (ISH). This guide covers formulation, assay setup, controls, and troubleshooting while limiting conclusions to the supplied product dossier rather than claiming paper-specific performance.
-
Azilsartan medoxomil monopotassium Workflows
2026-08-16
Build reproducible AT1-receptor assays and translational hypertension models with Azilsartan medoxomil monopotassium, also known as TAK 491. This guide connects concentration-controlled bench workflows with clinical evidence, sustained receptor blockade, and practical troubleshooting for cardiovascular and renal protection studies.
-
Balsalazide disodium: Applied IBD Workflows
2026-08-15
Build more informative ulcerative colitis assays by pairing Balsalazide disodium with bacterial activation controls, 5-ASA comparators, and pathway-level inflammation readouts. This workflow-focused guide covers solubilization, immunology assay design, inflammatory bowel disease models, troubleshooting, and translational interpretation.
-
EDC.HCl: Practical Coupling Workflow
2026-08-14
EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis and bioconjugation workflows. It is intended for controlled in vitro laboratory use; no reported in vivo or clinical data support therapeutic or clinical applications.
-
EDC.HCl: Practical Coupling Workflow
2026-08-14
EDC.HCl is a water-soluble carbodiimide that activates carboxyl groups for amide bond formation in peptide synthesis, bioconjugation, and related in vitro workflows. It should be handled as a laboratory reagent only; the supplied dossier reports no in vivo or clinical data and does not establish validated conditions for a specific substrate pair.
-
Fluconazole: Reliable Antifungal Assay Workflows
2026-08-13
This scenario-driven guide explains how Fluconazole, SKU B2094, can support reproducible antifungal susceptibility testing, Candida albicans infection models, and resistance studies. It addresses solvent control, concentration selection, data interpretation, storage, and practical product-selection criteria for research laboratories.
-
Drug Response Metrics in Cancer: Lessons from Schwartz
2026-08-13
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that drug-induced growth inhibition and cell death are related but non-equivalent responses. Its framework supports more informative cancer pharmacology by pairing viability measurements with time-resolved death analysis rather than interpreting a single endpoint as cytotoxicity.
-
Angiotensin 1/2 (5-7): From RAS to Translation
2026-08-12
A mechanistic and translational analysis of Angiotensin 1/2 (5-7), connecting its H2N-Ile-His-Pro-OH sequence to renin-angiotensin system research, hypertension models, and emerging SARS-CoV-2 spike–receptor biology.
-
CK2 and ERK8 Inhibitor: Assay Design
2026-08-12
The CK2 and ERK8 inhibitor B7464 is a small molecule inhibitor for dissecting kinase-dependent signaling. This article explains how to use it responsibly alongside phase-separation assays inspired by SARS-CoV-2 nucleocapsid research, without overextending the evidence.
-
Dextromethorphan Hydrobromide: Translational Insight
2026-08-11
Dextromethorphan hydrobromide is more than a catalog reagent: it is a mechanistic probe for connecting NMDA-linked excitotoxicity, ion-channel modulation, and neuroprotection research. This article outlines how to design stronger validation workflows, interpret cerebral ischemia models cautiously, and borrow translational lessons from an allosteric PDK4 inhibitor study without conflating metabolic and neurological mechanisms.